59665-93-9

Basic information

• Product Name: 8-Amino-4-methoxyquinoline
• Synonyms: 8-Amino-4-methoxyquinoline;4-Methoxyquinolin-8-aMine;4-Methoxy-8-aminoquinoline;8-Quinolinamine, 4-methoxy-;8-Amino-4-Methoxyquinoline(WX609252)
• CAS NO: 59665-93-9
• Molecular Formula: C10H10N2O
• Molecular Weight: 174.2
• Product Categories: organic building block
• Mol File: 59665-93-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 8-Amino-4-methoxyquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Amino-4-methoxyquinoline(59665-93-9)
• EPA Substance Registry System: 8-Amino-4-methoxyquinoline(59665-93-9)

Safety Data

• Hazardous Substances Data: 59665-93-9(Hazardous Substances Data)

Upstream product

• 86-98-6 4,7-dichloroquinoline 
• 5330-86-9 4,7-dichloro-8-nitro-quinoline 
• 1394083-95-4 7-Chloro-4-methoxy-8-nitro-quinoline 
• 1394083-96-5 7-chloro-4-methoxy-quinolin-8-ylamine 
• 611-35-8 4-chloroquinoline 
• 23833-99-0 4-chloro-8-nitroquinoline 
• 89770-28-5 4-methoxy-8-nitroquinoline 

Relevant articles and documents

Visible-Light-Photocatalyzed Reductions of N-Heterocyclic Nitroaryls to Anilines Utilizing Ascorbic Acid Reductant

A photoreductive protocol utilizing [Ru(bpy)3]2+ photocatalyst, blue light LEDs, and ascorbic acid (AscH2) has been developed to reduce nitro N-heteroaryls to the corresponding anilines. Based on experimental and computational results and previous studies, we propose that the reaction proceeds via proton-coupled electron transfer between AscH2, photocatalyst, and the nitro N-heteroaryl. The method offers a green catalytic procedure to reduce, e.g., 4-/8-nitroquinolines to the corresponding aminoquinolines, substructures present in important antimalarial drugs.

Novel Sulfonaminoquinoline Hepcidin Antagonists

The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.